🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564704
Treatments Being Tested
This study will test if adding ruxolitinib to standard multi-drug chemother...
Status
Recruiting
Location
University of Chicago Medical Center
Start Date
2019-05-28
Trial ID
NCT03571321
H. Lee Moffitt Cancer Center and Research Institute will be the Sunshine Pr...
Status
Completed
Location
Holtz Children's Hospital University of Miami Miller School of Medicine
Start Date
2011-07-18
Trial ID
NCT01324180
Treatments Being Tested
Evaluate the response (complete hematologic response \[CHR\], complete cyto...
Status
Unknown
Location
Hospital Germans Trias i Pujol
Start Date
2016-06
Trial ID
NCT02776605
Leukemia cells grow and divide fast and out of control. In normal cells, ce...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2018-04-20
Trial ID
NCT03515200
Randomized phase III trial to compare the effectiveness of different chemot...
Status
Completed
Location
Children's Oncology Group
Start Date
1996-08
Trial ID
NCT00002798
An experimental drug called EZN-3042 targets survivin, a protein expressed ...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2010-08-24
Trial ID
NCT01186328
Treatments Being Tested
The main purpose of this study is to find out how well participants with re...
Status
Completed
Location
Rady Children's Hospital and Health Center
Start Date
2003-11
Trial ID
NCT00186875
Treatments Being Tested
HEM-iSMART is a master protocol which investigates multiple investigational...
Status
Recruiting
Location
St. Anna Kinderspital
Start Date
2025-10-01
Trial ID
NCT05751044
Treatments Being Tested
This is a interventional phase II study aiming to examine the complete resp...
Status
Recruiting
Location
Instituto do Cancer do Estado de Sao Paulo
Start Date
2024-04-01
Trial ID
NCT06034561
Treatments Being Tested